astragalin
(Synonyms: 紫云英苷; Astragaline; 3-Glucosylkaempferol; Kaempferol 3-β-D-glucopyranoside) 目录号 : GN10561An anti-inflammatory flavonoid
Cas No.:480-10-4
Sample solution is provided at 25 µL, 10mM.
Astragalin is an inhibitor of eotaxin-1, PKCβ2 phosphorylation, activation of NF-κB/MAPK and PLCγ1 that correlated with oxidase in a dose dependent manner [1] [2].
Oxidative stress means disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell. And it is reported that oxidative stress can cause disruptions in normal mechanisms of cellular signaling, such as cancer development, Parkinson's disease, Alzheimer's disease, atherosclerosis, passive cutaneous reactions, inflammation, heart failure, myocardial infarction, Sickle Cell Disease, infection, and chronic fatigue syndrome [1, 3]. In human osteoaithritis chondrocyte cells, astragalin inhibited the activation of NF-κB and MAPK [2].
Astragalin is reported to have the ability of anti-oxidant effect. When tested with human basophilic cell line KU812, oral administration of astragalin inhibited the release of histamine and passive cutaneous reactions [4]. In airway epithelial BEAS-2B cells, astragalin treatment antagonized endotoxin-induced oxidative stress that is responsible to airway dysfunction and inflammation [1]. When tested with human red blood cells induced in the oxidative state, administration of astragalin suppressed the [3].
In mouse model with NC/Nga atopic dermatitis, astragalin treatment significantly suppressed the dermatitis development, scratching behavior and serum IgE elevation [4].
References:
[1]. Cho, I.H., et al., Astragalin inhibits airway eotaxin-1 induction and epithelial apoptosis through modulating oxidative stress-responsive MAPK signaling. BMC Pulm Med, 2014. 14: p. 122.
[2]. Ma, Z., et al., Astragalin inhibits IL-1beta-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-kappaB and MAPK activation. Int Immunopharmacol, 2015. 25(1): p. 83-87.
[3]. Choi, J., et al., Antioxidant effect of astragalin isolated from the leaves of Morus alba L. against free radical-induced oxidative hemolysis of human red blood cells. Arch Pharm Res, 2013. 36(7): p. 912-7.
[4]. Kotani, M., et al., Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol, 2000. 106(1 Pt 1): p. 159-66.
Cas No. | 480-10-4 | SDF | |
别名 | 紫云英苷; Astragaline; 3-Glucosylkaempferol; Kaempferol 3-β-D-glucopyranoside | ||
化学名 | 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | ||
Canonical SMILES | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O | ||
分子式 | C21H20O11 | 分子量 | 448.38 |
溶解度 | ≥ 44.8mg/mL in DMSO | 储存条件 | Store at 2-8°C,protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.2303 mL | 11.1513 mL | 22.3025 mL |
5 mM | 0.4461 mL | 2.2303 mL | 4.4605 mL |
10 mM | 0.223 mL | 1.1151 mL | 2.2303 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet